Infliximab/vedolizumabVarious toxicities, loss of response and drug exposure during pregnancy: 2 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1871卷 / 1期

关键词：

D O I：

10.1007/s40278-021-01732-2

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：213 / 213

相关论文

共 50 条

[1] HeparinVarious toxicities and drug exposure during pregnancy : 2 case reports
Reactions Weekly, 2023, 1961 (1) : 209 - 209
[2] Adalimumab/infliximab/vedolizumabVarious toxicities and lack of efficacy: 4 case reports
Reactions Weekly, 2022, 1888 (1) : 20 - 20
[3] PegvaliaseVarious toxicities and drug exposure during pregnancy: 9 case reports
Reactions Weekly, 2023, 1945 (1) : 434 - 434
[4] Magnesium-sulfateVarious toxicities and drug exposure during pregnancy: 2 case reports
Reactions Weekly, 2025, 2055 (1) : 199 - 199
[5] VedolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2019, 1750 (1) : 263 - 263
[6] VedolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2016, 1628 (1) : 365 - 365
[7] VedolizumabVarious toxicities: 3 case reports
Reactions Weekly, 2017, 1678 (1) : 173 - 173
[8] Azathioprine/infliximab/sulfasalazineVarious toxicities and drug exposure during pregnancy
Reactions Weekly, 2024, 2016 (1) : 80 - 80
[9] VedolizumabVarious toxicities: 5 case reports
Reactions Weekly, 2016, 1610 (1) : 150 - 150
[10] Azathioprine/prednisoneVarious toxicities following drug exposure during pregnancy and in-utero exposure during pregnancy : 2 case reports
Reactions Weekly, 2024, 2017 (1) : 90 - 90

← 1 2 3 4 5 →